Abeona Therapeutics Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Abeona Therapeutics Stock Forecast and Price Target
If Abeona Therapeutics's stock price reached the average yearlong target of $17.00 given by two well-known analysts in recent months, there would be a potential upside of approximately 432.92% from its last closing price in April, 2024. This potential increase is based on a high estimate of $36.00 and a low estimate of $12.00. If you are not interested in ABEO stock, you may still be interested in its competitors and their current standings.
432.92% Upside
Abeona Therapeutics Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Abeona Therapeutics's Price has grown, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $3.43 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
Abeona Therapeutics Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Abeona Therapeutics's Revenue has decreased from $10.00M to $1.41M – a 85.90% drop! In the next year, analysts believe that Revenue will reach $13.57M – an increase of 862.41%. For the next seven years, the forecast is for Revenue to grow by 21839.72%.
Abeona Therapeutics EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Abeona Therapeutics's EBITDA has grown by 1.75%, rising from $-43.92M to $-44.69M. For the next year, analysts predict that EBITDA will reach $-47.61M – an increase of 6.53%. Over the next eight years, experts believe that Abeona Therapeutics's EBITDA will grow at a rate of 6.93%.
Abeona Therapeutics EBIT Forecast for 2023 - 2025 - 2030
Abeona Therapeutics's EBIT has decreased In the last two years, from $-48.50M to $-45.26M – a 6.68% drop. In the next year, analysts predict that EBIT will jump to $-46.23M – up 2.14% from the current level. In 2030, professionals predict that Abeona Therapeutics's EBIT will decrease by 454.62%, to $160.50M.
Abeona Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Abeona Therapeutics's EPS has grown, rising from $-22.75 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $-1.77 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.